July 19, 2018

Opioid use before total joint replacements linked to higher readmission, revision rates

By: Judy Mathias

Editor's Note

Preoperative opioid use was associated with significantly increased risks of early revisions and 30-day readmissions after total knee and total hip arthroplasties, this study finds.

The study included 324,154 patients in a 1-year follow-up group and 159,822 in a 3-year follow-up group.

For total knee patients, the hospital readmission rate was 4.82% for those with no preoperative opioid use and 6.17% for those with more than 60 days of opioid use. For total hip patients, readmission rates were 3.71% and 5.85%, respectively.

At 1-year follow-up, the rate of total knee revisions was 1.07% for those with no preoperative opioid use and 2.14% for those with prolonged use. For total hip patients, the revision rates were 0.38% and 1.10%, respectively.

The increased risks associated with prolonged preoperative opioid use were also significant in the 3-year follow-up group.

The findings illustrate the increased risk for poor outcomes and increased postoperative healthcare utilization for patients with prolonged opioid use before total hip and knee replacement, the authors say.


Get OR Manager Updates

Sign Up Now
Latest Issue of OR Manager
October 2022
Video Spotlight
Live chat by BoldChat